Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
McKesson
Moodys
Merck
Johnson and Johnson

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020068

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 020068 describes FOSCAVIR, which is a drug marketed by Clinigen Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the FOSCAVIR profile page.

The generic ingredient in FOSCAVIR is foscarnet sodium. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the foscarnet sodium profile page.
Summary for 020068
Tradename:FOSCAVIR
Applicant:Clinigen Hlthcare
Ingredient:foscarnet sodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020068
Medical Subject Heading (MeSH) Categories for 020068
Suppliers and Packaging for NDA: 020068
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068 NDA Clinigen Healthcare Ltd. 76310-024 76310-024-01 10 CARTON in 1 CARTON (76310-024-01) > 1 BOTTLE in 1 CARTON (76310-024-11) > 250 mL in 1 BOTTLE
FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068 NDA Clinigen Healthcare Ltd. 76310-024 76310-024-25 10 CARTON in 1 CARTON (76310-024-25) > 1 BOTTLE in 1 CARTON (76310-024-15) > 250 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2.4GM/100ML
Approval Date:Sep 27, 1991TE:RLD:Yes

Expired US Patents for NDA 020068

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991   Start Trial   Start Trial
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991   Start Trial   Start Trial
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991   Start Trial   Start Trial
Clinigen Hlthcare FOSCAVIR foscarnet sodium INJECTABLE;INJECTION 020068-001 Sep 27, 1991   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
AstraZeneca
Harvard Business School
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.